Dive deep into the world of Next-Generation Sequencing (NGS) tests in our 2022 Targeted Therapies Forum’s breakout session. Esteemed oncologists Dr. Seetharamu and Dagogo-Jack elucidate the contrasts between RNA and DNA testing methodologies for NSCLC. Unravel the intricacies, advantages, and clinical implications of each method, providing clinicians and patients with a clearer perspective on these critical diagnostic tools.
We extend our gratitude to our steadfast sponsors: #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech.
Stay at the forefront of oncological advancements. Visit http://cancerGRACE.org/ and engage in insightful discussions at https://cancergrace.org/forum.